HRT Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.1M | Buy |
87,114
+41,056
| +89% | +$5.13M | 0.03% | 581 |
|
|
2025
Q4 | $5.62M | Buy |
+46,058
| New | +$5.28M | 0.02% | 731 |
|
|
2025
Q1 | – | Sell |
-28,402
| Closed | -$2.56M | – | 3505 |
|
|
2024
Q4 | $2.56M | Sell |
28,402
-187,968
| -87% | -$18.2M | 0.01% | 648 |
|
|
2024
Q3 | $21.4M | Buy |
216,370
+169,853
| +365% | +$16.7M | 0.11% | 111 |
|
|
2024
Q2 | $4.31M | Sell |
46,517
-169,457
| -78% | -$15.2M | 0.02% | 438 |
|
|
2024
Q1 | $20.5M | Buy |
215,974
+187,374
| +655% | +$17.4M | 0.13% | 78 |
|
|
2023
Q4 | $2.55M | Buy |
+28,600
| New | +$2.12M | 0.02% | 543 |
|
|
2023
Q3 | – | Sell |
-332,073
| Closed | -$27.6M | – | 3202 |
|
|
2023
Q2 | $27.6M | Buy |
332,073
+44,435
| +15% | +$3.72M | 0.26% | 42 |
|
|
2023
Q1 | $21.9M | Buy |
+287,638
| New | +$23.9M | 0.27% | 56 |
|
|
2022
Q4 | – | Sell |
-367,107
| Closed | -$29.1M | – | 3263 |
|
|
2022
Q3 | $29.1M | Buy |
+367,107
| New | +$30.9M | 0.31% | 53 |
|
|
2022
Q2 | – | Sell |
-315,277
| Closed | -$28.3M | – | 3848 |
|
|
2022
Q1 | $28.3M | Buy |
315,277
+222,808
| +241% | +$20.6M | 0.2% | 56 |
|
|
2021
Q4 | $10.4M | Sell |
92,469
-95,411
| -51% | -$11.5M | 0.06% | 158 |
|
|
2021
Q3 | $23.6M | Buy |
187,880
+116,614
| +164% | +$15M | 0.14% | 74 |
|
|
2021
Q2 | $9.65M | Sell |
71,266
-167,276
| -70% | -$22M | 0.09% | 189 |
|
|
2021
Q1 | $32.4M | Buy |
238,542
+183,981
| +337% | +$27.5M | 0.33% | 35 |
|
|
2020
Q4 | $7.68M | Sell |
54,561
-173,567
| -76% | -$22.2M | 0.15% | 108 |
|
|
2020
Q3 | $25.4M | Buy |
+228,128
| New | +$25.6M | 0.74% | 22 |
|
|
2020
Q1 | – | Sell |
-98,596
| Closed | -$9.38M | – | 1427 |
|
|
2019
Q4 | $9.38M | Sell |
98,596
-314,099
| -76% | -$27.2M | 0.4% | 35 |
|
|
2019
Q3 | $31.5M | Buy |
412,695
+357,732
| +651% | +$29.7M | 1.49% | 9 |
|
|
2019
Q2 | $4.82M | Buy |
+54,963
| New | +$4.69M | 0.3% | 75 |
|
|
2019
Q1 | – | Sell |
-82,754
| Closed | -$5.94M | – | 821 |
|
|
2018
Q4 | $5.94M | Buy |
82,754
+41,528
| +101% | +$3.35M | 0.85% | 27 |
|
|
2018
Q3 | $3.95M | Buy |
41,226
+38,384
| +1,351% | +$3.72M | 0.62% | 36 |
|
|
2018
Q2 | $270K | Buy |
+2,842
| New | +$261K | 0.1% | 162 |
|
|
2018
Q1 | – | Sell |
-5,938
| Closed | -$503K | – | 263 |
|
|
2017
Q4 | $503K | Buy |
5,938
+404
| +7% | +$33.8K | 0.51% | 36 |
|
|
2017
Q3 | $479K | Buy |
5,534
+1,939
| +54% | +$155K | 0.59% | 25 |
|
|
2017
Q2 | $277K | Sell |
3,595
-86,990
| -96% | -$6.17M | 0.44% | 28 |
|
|
2017
Q1 | $6.28M | Sell |
90,585
-16,451
| -15% | -$1.1M | 5.86% | 3 |
|
|
2016
Q4 | $6.33M | Buy |
+107,036
| New | +$6.61M | 8.08% | 2 |
|
|
2016
Q3 | – | Sell |
-115,395
| Closed | -$6.24M | – | 178 |
|
|
2016
Q2 | $6.24M | Buy |
115,395
+10,507
| +10% | +$576K | 3.79% | 4 |
|
|
2016
Q1 | $5.42M | Buy |
104,888
+30,758
| +41% | +$1.6M | 5.66% | 3 |
|
|
2015
Q4 | $5.2M | Buy |
74,130
+32,650
| +79% | +$2.23M | 6.3% | 2 |
|
|
2015
Q3 | $2.58M | Buy |
+41,480
| New | +$3.27M | 2.2% | 8 |
|
|
2015
Q2 | – | Sell |
-34,914
| Closed | -$2.62M | – | 193 |
|
|
2015
Q1 | $2.62M | Hold |
34,914
| – | – | 3.36% | 6 |
|
|
2014
Q4 | $2.17M | Buy |
+34,914
| New | +$1.99M | 3.06% | 5 |
|
Other funds holding XBI
HRT Financial's XBI Position: Q1 2026 in Review
HRT Financial increased its State Street SPDR S&P Biotech ETF (XBI) stake by 89% in Q1 2026, buying an estimated $5.13M and bringing the position to 87,114 shares worth $11.1M. The position accounts for 0.03% of the portfolio, ranked #581.
HRT Financial first reported a position in XBI in Q4 2014 and has held it in 34 quarters since. The position peaked at $32.4M in Q1 2021. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- HRT Financial held 87,114 shares of State Street SPDR S&P Biotech ETF worth $11.1M as of Q1 2026.
- HRT Financial bought 41,056 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $5.13M.
- State Street SPDR S&P Biotech ETF made up 0.03% of HRT Financial's portfolio in Q1 2026, its #581 holding.
- HRT Financial first reported a position in State Street SPDR S&P Biotech ETF in Q4 2014 and has held it in 34 quarters since.
- HRT Financial's State Street SPDR S&P Biotech ETF position peaked at $32.4M in Q1 2021.
- 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.